Milestone Scientific Inc (MLSS) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Milestone Scientific Inc   (NYSEAMER: MLSS)

Milestone Scientific Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Milestone Scientific Inc in the second quarter 2026?
Milestone Scientific Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -149.08%.

Within the Medical Equipment & Supplies industry 142 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3617 to 3723.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 3.91 % -48.8 % -51.78 % -64.7 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 -5 -6 -7 -7
Return On Equity (TTM) -149.08 % -166.28 % -173.86 % -164.78 % -133.76 %
MLSS's Total Ranking # 3723 # 3617 # 3244 # 3427 # 2880
Equity (TTM) in Millions 3 2 3 3 3
Seq. Equity Change 51.9 % -18.76 % 10.33 % -23.68 % -25.15 %
Seq. Net Income Change - - - - -

Back to MLSS Management Effectiveness >> MLSS's 5 Years Annual ROE >> Compare MLSS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 143
Sector # 620
Overall # 3723

Return On Equity Statistics
High Average Low
44.48 %
-139.58 %
-2168.91 %
(Dec 31 2013)   (Mar 31 2020)



  News about Milestone Scientific Inc Return on Equity ROE

Milestone Scientific Sets New Industry Standard with Medicare's Fav-orable Pricing for CompuFlo Epidural System



Milestone Scientific has scored a significant victory in their mission to revolutionize pain management and improve patient outcomes. The company recently obtained favorable Medicare pricing approval for their cutting-edge CompuFlo Epidural System, marking a major milestone in their reimbursement strategy. The first Joint Medical Advisory Committee (JMAC) region to grant approval was Florida, giving Milestone Scientific access to a vast market of potential beneficiaries across the sunshine state.
The Medicare pricing approval is a testament to the efficacy and potential of the CompuFlo Epidural System. This groundbreaking technology provides physicians with real-time pressure feedback during epidural procedures, ensuring accurate medication delivery and ultimately improving patient safety and comfort. By gaining the support of Medicare, Milestone Scientific now has a solid foundation to accelerate the adoption of their innovative system, revolutionizing pain management in hospitals and clinics across Florida.



MLSS Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 3 6 8 10 16
Y / Y Equity Change -51.78 % -27.21 % -19.93 % -38.29 % 0.67 %
Net Income in Millions -6 -5 -7 -9 -7
Y / Y Net Income Change - - - - -
Return On Equity -203.45 % -80.81 % -87.13 % -87.67 % -42.41 %

Back to MLSS Management Effectiveness >> MLSS's 5 Years Annual ROE >> Compare MLSS ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MLSS's' Return on Equity at Yahoo Finance
MLSS's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MLSS's Competitors
Subscribers only: Roe for Milestone Scientific Inc 's Suppliers
Subscribers only: Return On Equity for MLSS's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE

Date modified: 2026-09-08T18:59:32+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.